Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells
Open Access
- 25 September 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 26 (13), 1954-1958
- https://doi.org/10.1038/sj.onc.1209994
Abstract
Mutational activation of BRAF is a frequent event in human malignant melanomas suggesting that BRAF-dependent signaling is conducive to melanoma cell growth and survival. Previously published work reported that melanoma cells exhibit constitutive anti-apoptotic nuclear factor κB (NF-κB) transcription factor activation triggered by proteolysis of its inhibitor IκB. IκB degradation is dependent upon its phosphorylation by the IκB kinase (IKK) complex and subsequent ubiquitination facilitated by β-Trcp E3 ubiquitin ligase. Here, we report that melanocytes expressing a conditionally oncogenic form of BRAFV600E exhibit enhanced β-Trcp expression, increased IKK activity and a concomitant increase in the rate of IκBα degradation. Conversely, inhibition of BRAF signaling using either a broad-spectrum Raf inhibitor (BAY 43-9006) or by selective knock-down of BRAFV600E expression by RNA interference in human melanoma cells leads to decreased IKK activity and β-Trcp expression, stabilization of IκB, inhibition of NF-κB transcriptional activity and sensitization of these cells to apoptosis. Taken together, these data support a model in which mutational activation of BRAF in human melanomas contributes to constitutive induction of NF-κB activity and to increased survival of melanoma cells.This publication has 22 references indexed in Scilit:
- NF‐κB activation in melanomaPigment Cell Research, 2006
- Faculty Opinions recommendation of Suppression of BRAF(V599E) in human melanoma abrogates transformation.Published by H1 Connect ,2003
- Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.2003
- A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?International Journal of Cancer, 2003
- The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB PathwaysImmunity, 2002
- Induction of Homologue of Slimb Ubiquitin Ligase Receptor by Mitogen SignalingPublished by Elsevier BV ,2002
- Inhibition of HOS expression and activities by Wnt pathwayOncogene, 2002
- Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.2001
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis.1999